Industry Spotlight

Recruitment milestone for Immuron NASH study

27 May 2016 via Biotech Dispatch: Immuron (ASX:IMC) has announced that its IMM-124E Phase II clinical trial for the treatment of NASH (Non-Alcoholic Steatohepatitis) has reached its 50 per cent recruitment milestone with 56 patients having been successfully randomise... | READ MORE

'A match made in heaven'

27 May 2016 via Biotech Dispatch: Industry has had to change its approach to innovation as the world becomes more inter-connected, according to Seema Kumar, Vice President, Innovation, Global Health, and Policy Communication, Johnson & Johnson. Kumar says externalis... | READ MORE

LBT will 'continue to grow and prosper' says retiring CEO

27 May 2016 via Biotech Dispatch: Retiring CEO of LBT Innovations (ASX:LBT), Lusia Guthrie, has delivered an upbeat message in her final note to shareholders. “Although this will be my final letter to you as the Chief Executive of LBT Innovations, I enter my r... | READ MORE

Coalition announces $7M for clinical trials

24 May 2016 via Biotech Dispatch: Health Minister Sussan Ley has announced a re-elected Coalition government will push for better regulatory harmonisation and mutual-recognition of clinical trials. Speaking at the Australian Clinical Trials Alliance 2016 Breakfast a... | READ MORE

Biotron compounds record activity against Zika

24 May 2016 via Biotech Dispatch: A significant boost for Biotron (ASX:BIT) after the Sydney-based company reported positive results from tests involving two compounds targeting Zika virus. Earlier this year, the World Health Organization (WHO) declared Zika virus a... | READ MORE

Clarity Pharmaceuticals completes $2M capital raise

May 24 2016 via Biotech Dispatch: Clarity Pharmaceuticals, an emerging Australian biotech company specialising in the treatment of serious disease, has raised $2 million to develop its clinical pipeline using its proprietary drug targeting technology. The investment... | READ MORE

2016 Victoria Prize for Science and Innovation and Victorian Fellowships

23 May 2016 via veski: Applications for two of Victoria's most prestigious science and innovation programs, the 2016 Victoria Prize for Science and Innovation and the 2016 Victoria Fellowships, are now open. The Victorian Government will offer two Victoria Prizes fo... | READ MORE

Croplife Australia Media Release: Don't play silly politics with farmers' livelihoods

20 May 2016 via Croplife Australia: The parliamentary debate on securing farmer choice in Western Australia is welcomed, however playing silly politics with farmers livelihoods by unnecessarily extending debate to delay or entirely prevent the vote on the GM moratori... | READ MORE

Phosphagenics expands agreements with Themis Medicare

19 May 2016 via Biotech Dispatch: Melbourne-based Phosphagenics (ASX:POH) has expanded its existing agreement with Themis Medicare for its TPM/Diclofenac gel to include an additional 16 geographical markets. TPM/Diclofenac gel is a topical non-steroidal anti-inflamm... | READ MORE

Adelaide welcomes medical technology sector

11 May 2016 via Biotech Dispatch: Creating a thriving and sustainable medical devices sector in Australia will be a key topic in the annual AusMedtech conference, held in Adelaide. The two-day event has brought together over 250 medtech professionals to explore adva... | READ MORE

Previous page | Next page
Jump to page